Insiders · Profile

Devroe Eric

Chief Operating Officer at Acrivon Therapeutics. Filing since 13 Jan 2026. CIK 0001950573

Company
Date
Role
Action
Shares
Amount
Of holding
18 Aug 2026
Chief Operating Officer
Sold at will
604
$1.21K
0.4%
13 Jan 2026
Chief Operating Officer
Bought
10,000
$17.22K
15.3%
2 decisions on file.